Singapore markets closed
Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
66,770.41 +1,542.86 (+2.37%) CMC Crypto 200
1,364.50 -9.34 (-0.68%)
ResMed Inc (RME.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
At close: 08:24AM CEST
| Previous close | 201.80 |
| Open | 201.50 |
| Bid | 200.60 x 30000 |
| Ask | 203.10 x 30000 |
| Day's range | 201.50 - 201.50 |
| 52-week range | 126.90 - 208.20 |
| Volume | |
| Avg. volume | 34 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ZacksHaemonetics' (HAE) Hospital & Plasma Segments, Innovation Aid
Haemonetics' (HAE) hospital portfolio is evolving and helping to create new opportunities for growth and diversification.
ZacksMaravai (MRVI) Advances in RNA Research With New Collaboration
Per Maravai LifeSciences (MRVI) management, this development by TriLink is set to advance nucleic acid-based therapies.
ZacksHaemonetics (HAE) Stock Up 10.9% YTD: Will the Rally Continue?
Investors are optimistic about Haemonetics (HAE) led by its strategic focus on establishing leading positions in high-growth markets to generate solid financial returns.
© 2024 Yahoo. All rights reserved.